On 26th November Dr Alan Stewart attended a networking dinner at the Royal College of Surgeons in Edinburgh to help launch a new charity focused on developing a cure for age-related macular degeneration (AMD), a debilitating eye disease that affects millions of people worldwide. In the UK alone there are more than 685,000 people with significant sight loss as a consequence of late-stage AMD. The new charity has been founded by four leading site loss charities, Blind Veterans UK, Fight for Sight, the Macular Society and Scottish War Blinded.
During a recent trip to the USA, Dr Alan Stewart visited the laboratory of Prof Wladek Minor in the Department of Biochemistry and Biophysics at the University of Virginia – Charlotteslville and on the 15th November gave a seminar there entitled “Allosteric regulation of plasma zinc dynamics by free fatty acids: A potential driver of cardiovascular complications in disease states”. He then went on to Dallas, Texas to attend the Proteomics-2018 conference (19th-20th November) where he gave an invited talk entitled “The hydroxyapatite interactome in age-related macular degeneration”.